Highland Primary Care Nhs Trust
Total Page:16
File Type:pdf, Size:1020Kb
PHARMACY PRACTICES COMMITTEE MEETING Tuesday, 29 January, 2013 at 11.30am James Cameron Community Centre, Limetree Avenue, Inverness, IV3 5RH Application by CONON BRIDGE PHARMACY LIMITED for the provision of general pharmaceutical services at 30 Laurel Avenue, Dalneigh, Inverness, IV3 5RP PRESENT Bill Brackenridge(Chair) Maureen Thomson (Lay Member) Margaret Thomson (Lay Member) Michael Roberts (Lay member) Alison MacRobbie (APC Non Contractor Nominate) Gareth Dixon ( APC Contractor Nominate) Nicola MacDonald (APC Contractor Nominate) In Attendance Andrew J Green (Area Regulations, Contracts & Controlled Drugs Governance Pharmacist) Helen M MacDonald (Community Pharmacy Business Manager) Aileen Trappitt (Community Pharmacy Administration Assistant) Alan Horsburgh, Conon Bridge Pharmacy Limited, Applicant Alasdair Shearer, Rowlands Pharmacy Janice Robertson, Rowlands Pharmacy Support Tom Arnott, Lloydspharmacy Stuart Finnie, Lloydspharmacy Support John Ross, Kinmylies Pharmacy Carmen Harrold, Kinmylies Pharmacy Support Apologies Area Pharmaceutical Committee of NHS Highland 1. The Chair welcomed everyone and asked all members to confirm that they had all received the papers for the hearing and had read and considered them. All members affirmed these points. 2. APPLICATION FOR INCLUSION IN THE BOARD’S PHARMACEUTICAL LIST Case No: PPC – Dalneigh, Inverness Conon Bridge Pharmacy Limited, 30 Laurel Avenue, Dalneigh, Inverness, IV3 5RP The Chair asked each Committee member if there were any interests to declare in relation to the application being heard from Conon Bridge Pharmacy Limited. No interests were declared. 3. The Committee was asked to consider the application submitted by Conon Bridge Pharmacy Limited to provide general pharmaceutical services from premises sited at 30 Laurel Avenue, Dalneigh, Inverness, IV3 5RP under Regulation 5(10) of the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009, as amended. The Committee had to determine whether the granting of the application was necessary or desirable to secure the adequate provision of pharmaceutical services in the neighbourhood in which the Applicant’s proposed premises were located. The Committee, having previously been circulated with all the papers regarding the application from Conon Bridge Pharmacy Limited, agreed that the application should be considered by oral hearing. Conon Bridge Pharmacy Limited Dalneigh _ PPC 29 January 2013 NOTES.doc P1 Prior to the hearing, the Committee had, as a group, visited the vicinity surrounding the Applicant’s proposed premises, the existing pharmacies at Lloyds, Greig Street, Lloyds, Riverside, Ballifeary Lane, Rowlands, Grant Street and Kinmylies Pharmacy, Charleston Court, all in Inverness and facilities in the immediate area and surrounding areas of Dalneigh, Kinmylies, Merkinch, Park and Ballifeary where there was much social housing, four supermarkets, many small grocers shops, seven primary schools, two secondary schools, three GP surgeries, private and NHS dental practices, residential nursing homes, Scout Inverness District Hall, charitable support organisations, community halls, including the one where the hearing took place, The Highland Council Social Work and Children Resource Centre and churches were pointed out. They were then driven around the boundaries of the neighbourhood as defined by the Applicant and throughout the residential area, noting new housing being built on the green area between St Valery Avenue and the canal and many walkways and footpaths were also highlighted. The Committee then visited the proposed premises where the Applicant was on hand with a sketch of his proposed plans and to guide the Committee around the premises. The Committee then returned to the James Cameron Community Centre, Limetree Avenue, Inverness, IV3 5RH where the hearing was to be held. The hearing was convened under paragraph 3(2) of Schedule 3 to the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009 as amended (“the Regulations”). In terms of this paragraph, the Pharmacy Practices Committee “shall determine an application in such a manner as it thinks fit”. In terms of Regulation 5(10) of the Regulations, the question for the Pharmacy Practices Committee is whether “the provision of pharmaceutical services at the premises named in the application is necessary or desirable to secure adequate provision of pharmaceutical service in the neighbourhood in which the premises are located by persons whose names are included in the Pharmaceutical List.” The Applicant, Support and Interested parties were invited into the meeting at around 11.45am 4. The Chair welcomed:- The Applicant, Conon Bridge Pharmacy Limited represented by Alan Horsburgh, the Interested Parties who had submitted written representations during the consultation period and who had chosen to attend the hearing, were Alasdair Shearer, Rowlands Pharmacy and Janice Robertson, Rowlands Pharmacy support, Tom Arnott, Lloydspharmacy, Stuart Finnie, Lloydspharmacy support, John Ross, Kinmylies Pharmacy and Carmen Harrold, Kinmylies Pharmacy support, (“the Interested parties”). It was noted that the Area Pharmaceutical Committee had submitted a paper for reading out at the hearing and their apologies in advance to the Health Board. The Chair then invited the Committee members to introduce themselves. Committee members introduced themselves to the Applicant and all other parties. The Chair asked the Applicant and the Interested Parties to confirm that they were not attending the Committee in the capacity of solicitor, counsel or paid advocate. They each confirmed that they were not. 5. The Chair reminded everyone that the meeting had been convened to hear the application from Conon Bridge Pharmacy Limited for the provision of general pharmaceutical services at 30 Laurel Avenue, Dalneigh, Inverness, IV3 5RP. The application would be considered against the legal test contained in Regulation 5(10) of the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009, as amended. Conon Bridge Pharmacy Limited Dalneigh _ PPC 29 January 2013 NOTES.doc P2 6. Regulation 5(10) was read out: An application shall be granted if the Board is satisfied that the provision of the pharmaceutical services at the premises is necessary or desirable in order to secure adequate provision of pharmaceutical services in the neighbourhood in which the premises are located. 7. The Chair then described the format of the hearing, reminding those attending that no new evidence could be introduced at the summing up. The procedure adopted by the Committee at the hearing was that the Chair asked the Applicant to make his submission. There followed the opportunity for the Interested Parties and the Committee to ask questions. The Interested Parties would then make their submissions. There followed the opportunity for the Applicant and the Committee to ask questions of the Interested Parties in turn. The Interested parties and the Applicant were then given the opportunity to sum up. The Chair then asked the Applicant to give his statement. 7.1. The Applicant’s Case Alan Horsburgh, Conon Bridge Pharmacy Limited stated “I am Alan Horsburgh of Conon Bridge Pharmacy Limited and I would like to start by thanking the Committee for their time and for allowing me to present my evidence in support of the application. I have lots of evidence but will try to be as concise as possible. The application is for premises at 30 Laurel Avenue in Dalneigh and we propose to provide a full range of pharmaceutical services from 8.30 am to 6pm, Monday to Friday and 9am to 5pm on Saturdays. I believe the area to be considered is the neighbourhood of Dalneigh in Inverness which is bounded by the canal to the west where it runs north to its meeting with Telford Street. The boundary then runs east along Telford Street and then into and along Kenneth Street to the A82. This is the eastern boundary, running south to where it crosses the canal. This neighbourhood has a population of 5,547. This area has all the amenities one would expect of a neighbourhood such as schooling, convenience stores and a local post office. The population of 5,547 has remained stable and has a mixture of older residents and young families which, increasingly, are eastern European immigrants with low levels of both spoken and written English. There are small pockets of development planned such as 26 homes at St Valery Avenue for the elderly and disabled. The percentage of the population in Dalneigh on a deprived income is 22% compared to 11% for the rest of the Highland Health Board area; 9.5% for those aged 16-24 on jobseekers allowance compared to 5.7% for the rest of the Health Board area; 6.9% of those aged between 25 to 49 on jobseekers allowance compared to 3.5% for the area; for those aged 50 to pensionable age, 4.8% of the Dalneigh population are in receipt of jobseekers allowance compared to 2.1% in the rest of the Board area. The population of the community in Dalneigh who are employment deprived is 18% compared to 9% in the rest of the Health Board area; and the total on income support is 695 which is 11% of the Dalneigh population compared to 6,370 in the rest of Highland. There is 4.5% of the total Health Board population living in Dalneigh and 22.3% of these claiming pension credits compared to 13.3% in the rest of the area with 23.5% of 16-24 years of age receiving benefits compared to 13.3% elsewhere in Highland. Conon Bridge Pharmacy Limited Dalneigh _ PPC 29 January 2013 NOTES.doc P3 Those aged 25-49 on benefits are 25.4% of the Dalneigh population compared to 13.5% in the rest of the area and those between the age of 50 and pension age receiving benefits are 33% compared to 18.5% for the rest of the Highland Health Board area – there are a lot of facts and figures here but this paints a picture of low income and employment deprivation, creating locally an area of great inequality from the rest of Inverness. This can be expressed in terms of deprivation – income and work prospects and the associated lack of transport as well as the all important impact this has on health outcomes.